The liquid biopsy series: A cytopathological perspective

In the modern era of personalised medicine, the correct assessment of the genomic landscape for patients affected by cancer with haematological malignancies is crucial. In this scenario, liquid biopsy represents not only an alternative but a complementary source of tumour nucleic acids to tissue in order to guarantee the best clinical management for these patients.